Jay R. Luly Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jay R. Luly.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jay R. Luly. Jay R. Luly is President and CEO in ENANTA PHARMACEUTICALS INC ($ENTA).
Latest Insider Trading Transactions of Jay R. Luly
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 42.52 | 2,201 | 93,587 | 681,488 | 683.7 K to 681.5 K (-0.32 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.00 | 7,500 | 0 | 683,689 | 676.2 K to 683.7 K (+1.11 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 52.76 | 3,122 | 164,717 | 649,689 | 652.8 K to 649.7 K (-0.48 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,910 | 0 | 652,811 | 643.9 K to 652.8 K (+1.38 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 1,485 | 0 | 643,901 | 642.4 K to 643.9 K (+0.23 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 52.76 | 3,122 | 164,717 | 649,689 | 652.8 K to 649.7 K (-0.48 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,910 | 0 | 652,811 | 643.9 K to 652.8 K (+1.38 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 1,485 | 0 | 643,901 | 642.4 K to 643.9 K (+0.23 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 63.88 | 3,330 | 212,720 | 642,416 | 645.7 K to 642.4 K (-0.52 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.00 | 7,500 | 0 | 645,746 | 638.2 K to 645.7 K (+1.18 %) |
| Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 63.35 | 110,000 | 6,968,500 | 110,000 | |
| Oct 09 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 14.18 | 7,052 | 99,997 | 16,149 | |
| Oct 09 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 14.18 | 7,052 | 99,997 | 638,246 | 631.2 K to 638.2 K (+1.12 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 88.88 | 20,730 | 1,842,482 | 631,194 | 651.9 K to 631.2 K (-3.18 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 36,000 | 0 | 651,924 | 615.9 K to 651.9 K (+5.84 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 14,400 | 0 | 615,924 | 601.5 K to 615.9 K (+2.39 %) |
| Nov 20 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 81.20 | 68,000 | 5,521,600 | 68,000 | |
| Jul 30 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 11.77 | 8,498 | 99,990 | 0 | |
| Jul 30 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 11.77 | 8,498 | 99,990 | 601,524 | 593 K to 601.5 K (+1.43 %) |
| Jul 09 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 127.12 | 4,125 | 524,379 | 593,026 | 597.2 K to 593 K (-0.69 %) |
| Jul 09 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 126.36 | 7,738 | 977,788 | 597,151 | 604.9 K to 597.2 K (-1.28 %) |
| Jul 09 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 125.27 | 7,538 | 944,265 | 604,889 | 612.4 K to 604.9 K (-1.23 %) |
| Jul 09 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 124.26 | 12,622 | 1,568,460 | 612,427 | 625 K to 612.4 K (-2.02 %) |
| Jul 09 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 123.81 | 2,977 | 368,568 | 625,049 | 628 K to 625 K (-0.47 %) |
| May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 105.83 | 10,968 | 1,160,742 | 628,026 | 639 K to 628 K (-1.72 %) |
| May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 105.82 | 14,032 | 1,484,913 | 638,994 | 653 K to 639 K (-2.15 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 76.85 | 11,132 | 855,439 | 653,026 | 664.2 K to 653 K (-1.68 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 20,737 | 0 | 664,158 | 643.4 K to 664.2 K (+3.22 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,600 | 0 | 643,421 | 634.8 K to 643.4 K (+1.35 %) |
| Nov 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 48.52 | 100,000 | 4,852,000 | 100,000 | |
| Apr 14 2017 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 13,925 | 194,950 | 13,925 | |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 29.82 | 2,278 | 67,919 | 634,821 | 637.1 K to 634.8 K (-0.36 %) |
| Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 6,800 | 0 | 637,099 | 630.3 K to 637.1 K (+1.08 %) |
| Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 30.00 | 120,000 | 3,600,000 | 120,000 | |
| Sep 29 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,957 | 97,398 | 6,957 | |
| Jul 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,967 | 97,538 | 6,967 | |
| Jun 13 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 2.97 | 41,645 | 123,848 | 0 | |
| Jun 13 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 2.97 | 41,645 | 123,848 | 630,299 | 588.7 K to 630.3 K (+7.07 %) |
| May 10 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 2.97 | 25,000 | 74,348 | 41,645 | |
| May 10 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 2.97 | 25,000 | 74,348 | 588,654 | 563.7 K to 588.7 K (+4.44 %) |
| Mar 09 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 2.54 | 18,561 | 47,199 | 0 | |
| Mar 09 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 2.54 | 18,561 | 47,199 | 563,654 | 545.1 K to 563.7 K (+3.41 %) |
| Jan 11 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,957 | 97,398 | 6,957 | |
| Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 31.42 | 110,000 | 3,456,200 | 110,000 | |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.21 | 9,280 | 11,199 | 0 | |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.51 | 18,561 | 27,999 | 0 | |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.98 | 18,561 | 36,799 | 0 | |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.29 | 22,298 | 28,831 | 0 | |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.21 | 9,280 | 11,199 | 545,093 | 535.8 K to 545.1 K (+1.73 %) |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.51 | 18,561 | 27,999 | 535,813 | 517.3 K to 535.8 K (+3.59 %) |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.98 | 18,561 | 36,799 | 517,252 | 498.7 K to 517.3 K (+3.72 %) |
| Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.29 | 22,298 | 28,831 | 498,691 | 476.4 K to 498.7 K (+4.68 %) |
| Mar 10 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 34.88 | 100 | 3,488 | 476,393 | 476.5 K to 476.4 K (-0.02 %) |
| Mar 10 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 34.07 | 3,600 | 122,658 | 476,493 | 480.1 K to 476.5 K (-0.75 %) |
| Mar 10 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 33.13 | 11,300 | 374,375 | 480,093 | 491.4 K to 480.1 K (-2.30 %) |
| Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 35.35 | 15,000 | 530,289 | 491,393 | 506.4 K to 491.4 K (-2.96 %) |
| Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 50.97 | 4,000 | 203,894 | 506,393 | 510.4 K to 506.4 K (-0.78 %) |
| Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 50.23 | 11,000 | 552,569 | 510,393 | 521.4 K to 510.4 K (-2.11 %) |
| Dec 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.73 | 7,055 | 5,169 | 0 | |
| Dec 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.73 | 7,055 | 5,169 | 521,393 | 514.3 K to 521.4 K (+1.37 %) |
| Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 46.97 | 2,400 | 112,727 | 514,338 | 516.7 K to 514.3 K (-0.46 %) |
| Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 45.96 | 1,200 | 55,152 | 516,738 | 517.9 K to 516.7 K (-0.23 %) |
| Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 44.99 | 11,400 | 512,936 | 517,938 | 529.3 K to 517.9 K (-2.15 %) |
| Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 44.00 | 85,250 | 3,751,000 | 85,250 | |
| Nov 04 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 43.05 | 3,223 | 138,745 | 529,338 | 532.6 K to 529.3 K (-0.61 %) |
| Nov 04 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 42.38 | 11,777 | 499,067 | 532,561 | 544.3 K to 532.6 K (-2.16 %) |
| May 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,957 | 97,398 | 6,957 | |
| Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 40.71 | 500 | 20,355 | 544,338 | 544.8 K to 544.3 K (-0.09 %) |
| Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 40.22 | 2,200 | 88,487 | 544,838 | 547 K to 544.8 K (-0.40 %) |
| Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.92 | 12,300 | 478,700 | 547,038 | 559.3 K to 547 K (-2.20 %) |
| Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 39.32 | 2,685 | 105,576 | 559,338 | 562 K to 559.3 K (-0.48 %) |
| Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.77 | 3,615 | 140,136 | 562,023 | 565.6 K to 562 K (-0.64 %) |
| Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 37.61 | 3,700 | 139,156 | 565,638 | 569.3 K to 565.6 K (-0.65 %) |
| Feb 14 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.52 | 2,385 | 91,862 | 569,338 | 571.7 K to 569.3 K (-0.42 %) |
| Feb 14 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 37.81 | 3,415 | 129,113 | 571,723 | 575.1 K to 571.7 K (-0.59 %) |
| Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.73 | 7,445 | 5,455 | 7,055 | |
| Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.73 | 243,674 | 178,540 | 0 | |
| Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.73 | 7,445 | 5,455 | 575,138 | 567.7 K to 575.1 K (+1.31 %) |
| Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.73 | 243,674 | 178,540 | 567,693 | 324 K to 567.7 K (+75.20 %) |
| Jan 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 28.43 | 1,170 | 33,258 | 324,019 | 325.2 K to 324 K (-0.36 %) |
| Jan 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 27.96 | 4,630 | 129,441 | 325,189 | 329.8 K to 325.2 K (-1.40 %) |
| Dec 09 2013 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 29.66 | 25,000 | 741,500 | 25,000 | |
| Dec 06 2013 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 27.58 | 70,000 | 1,930,600 | 70,000 |
Page: 1